Hydrocephalus is a common and costly neurological condition caused by the overproduction and/or impaired resorption of cerebrospinal fluid (CSF). The current standard of care, ventricular catheters (shunts), is prone to failure, which can result in nonspecific symptoms such as headaches, dizziness, and nausea. Current diagnostic tools for shunt failure such as computed tomography (CT), magnetic resonance imaging (MRI), radionuclide shunt patency studies (RSPSs), and ice pack-mediated thermodilution have disadvantages including high cost, poor accuracy, inconvenience, and safety concerns. Here, we developed and tested a noninvasive, skin-mounted, wearable measurement platform that incorporates arrays of thermal sensors and actuators for precise, continuous, or intermittent measurements of flow through subdermal shunts, without the drawbacks of other methods. Systematic theoretical and experimental benchtop studies demonstrate high performance across a range of practical operating conditions. Advanced electronics designs serve as the basis of a wireless embodiment for continuous monitoring based on rechargeable batteries and data transmission using Bluetooth protocols. Clinical studies involving five patients validate the sensor's ability to detect the presence of CSF flow (P = 0.012) and further distinguish between baseline flow, diminished flow, and distal shunt failure. Last, we demonstrate processing algorithms to translate measured data into quantitative flow rate. The sensor designs, fabrication schemes, wireless architectures, and patient trials reported here represent an advance in hydrocephalus diagnostics with ability to visualize flow in a simple, user-friendly mode, accessible to the physician and patient alike.
INTRODUCTION
Ventricular shunts represent an essential component of clinical treatment for hydrocephalus, a common and debilitating neurological disorder that results from the overproduction and/or impaired reabsorption of cerebrospinal fluid (CSF) produced in the ventricular system of the brain (1) . Shunt assemblies typically involve two silicone catheters, connected upstream and downstream of a regulating valve, to drain excess CSF from the ventricle to a distal absorptive site. In this study, "ventricular shunt" refers to a shunt system consisting of a proximal catheter draining CSF from the ventricular system; a flow-, gravity-, or pressure-regulated valve; and a distal catheter draining fluid from the valve to the recipient site, such as the peritoneum, pleural cavity, or right atrium. Although effective in CSF diversion and prevention of the sequelae of hydrocephalus, shunts are highly prone to failure (2) . Clinical symptoms of shunt malfunction tend to be nonspecific, such as headache, nausea, and somnolence, thereby creating challenges in clinical diagnosis (3, 4) . Because ramifications of misdiagnosis can include severe morbidity and mortality, accurately identifying shunt malfunction or failure is critical in the appropriate care of patients with hydrocephalus.
Diagnostic tests to assess shunt function include computed tomography (CT), plain films (x-ray), magnetic resonance imaging (MRI), radionuclide shunt patency studies (RSPSs; or "shunt-o-gram"), shunt aspiration, and flow monitoring systems (5) (6) (7) . Each method, however, suffers from some combination of disadvantages, including excessive cost, poor reliability, low speeds, susceptibility to interference and patient discomfort, and potential for harm. CT scans and x-rays expose a vulnerable pediatric population to harmful radiation (1.57 ± 0.6 mSv and 1.87 ± 0.45 mSv, respectively). Shunted patients undergo an average of two CT scans annually that, over the course of the patient's lifetime, result in dangerous cumulative amounts of radiation exposure that have been linked to the onset of neurological and hematological malignancies (8, 9) . The MRI approach costs $3000 per study, the measurement can interfere with magnetic shunt valves, the availability is limited, and the wait times are typically long. Invasive testing in the form of RSPSs or simple aspiration is painful, time consuming, and potentially inaccurate and risks infection of the shunt system (10) (11) (12) (13) . Recent diagnostic entrants attempt to address these drawbacks but are limited by cumbersome, multistep protocols, in some cases including ice-mediated cooling, with equivocal or negative past clinical data (5, 7, 14, 15) . Ultimately, surgical intervention is required to assess and revise shunts in many patients. With risk of intraoperative complications and anesthetic exposure, gross procedural expenditures approach $67,000 per patient (16) . Because a considerable proportion of such operations reveal shunt systems with proper flow profiles, these unnecessary procedures represent a large burden on the health care system.
Here, we present a simple, noninvasive sensor platform that provides a low-cost, comfortable means for quantitatively assessing flow through cerebrospinal shunts, continuously or intermittently. The system exploits advances in materials, mechanics, and fabrication schemes that serve as the foundations for a class of electronics that is ultrathin (h < 100 mm), soft (E~70 kPa), lightweight (<10 mg/cm 2 ) , and skinlike in its physical properties, with resulting flexural rigidities that are nine orders of magnitude lower than those of traditional, rigid sensors. Such epidermal electronic devices support clinical grade accuracy in capturing body kinematics (17) , electrophysiological signals (18, 19) , soft tissue mechanical properties (20) , and chemical markers in sweat (21, 22) , among others. Specific device constructions allow for high-resolution skin thermography and precise measurements of the thermal conductivity and the thermal diffusivity of the skin. We extended recent work in quantifying macrovascular blood flow based on measurements of spatial anisotropies in thermal transport (23) to generate a soft, skin-interfaced sensor that can accurately measure flow through cerebrospinal shunts in real time, in a noninvasive, quantitative, and wireless manner. Benchtop evaluations, thermographic imaging, and finite element analysis (FEA) of the physics of heat transport revealed the effects of skin thermal properties and thickness, as well as device and catheter geometries. The results establish considerations in design for a range of practical operating conditions. Trials on five adult shunt recipients with a diverse range of etiologies and comparisons with CT, MRI, and RSPSs validated device function in vivo, along with advanced processing algorithms for quantitative determination of flow rates.
RESULTS

Dense arrays for flow visualization
Previous work from our group showed that arrays of epidermal temperature sensors and thermal actuators could be used to quantify anisotropies in thermal transport induced by macrovascular blood flow through the skin (23, 24) . The epidermal sensing array (ESA) architectures and fabrication schemes used here increased the number of sensors by nearly a factor of 10, and the density of these elements by a factor of 4, using clusters distributed around a central thermal actuator to provide the precision and spatial resolution necessary for characterizing flow through shunts (Fig. 1, A and B) .
Connecting unique combinations of rows (to supply a sensing voltage, V sup ) and columns (to measure a resulting current, I meas ) enabled individual addressing of each temperature-sensing element in the array (Fig. 1C) . Operation of the thermal actuator (Fig. 1C) resulted in a spatiotemporal pattern of temperatures that was captured by high-speed, automated interrogation of the sensors in the array. Arrays in square geometries with an equal number of input and output lines (10 × 10) mitigated effects of parasitic current pathways, as shown by theoretical and experimental comparisons of current distributions in square and nonsquare arrays (fig. S1) for our system ( fig. S2 ). The ease of fabrication and physical robustness (Fig. 1D ) of metallic resistive sensor elements made them attractive options compared to semiconductor devices, composite organic thermistors, and others (25) (26) (27) .
Thermal transport occurred most effectively along the direction of flow (Fig. 1E ), thereby creating a pronounced anisotropy in the temperature distribution, with a magnitude that can be quantitatively related to the volumetric flow rate. The layout of the sensing elements allowed accurate measurements of this anisotropy for cases relevant to flow through subcutaneous shunts with typical dimensions.
Two regions of the ESA (upstream and downstream, referring to sensor position with respect to the flow direction and thermal actuator) each contained a set of 50 temperature sensors ( Fig. 2A) . Here, U i,j represents the temperature recorded by the upstream sensor at the ith row and jth column, and D i,k represents the downstream sensor at the ith row and kth column, where i ranges from 1 to 10 and j and k range from 1 to 5. The numbering for the jth column begins from the right, whereas the kth column begins from the left to maintain physical representation of sensor position ( Fig. 2A ). Temperature differentials (DT i,m = D i,k -U i,j ; m ranges from 1 to 10) for each equidistant sensor pair with respect to the thermal actuator (where j = k, paired colors in Fig. 2A ) define the degree of thermal anisotropy that results from flow. Values of DT for sensor pairs A and B, which directly overlaid the catheter, exhibited strong thermal anisotropy under two different flow conditions (0.02 and 0.2 ml/min) within an established range for CSF flow (Fig. 2B) (28) . Sensor location B displayed a higher sensitivity to flow than location A because of the reduced effect of direct thermal conduction from the actuator, relative to anisotropic thermal transport due to fluid flow. Measurements of DT for distal sensor pairs orthogonal to the flow direction showed weak anisotropy (Fig. 2B , location C), whereas distal pairs parallel to the flow direction (Fig. 2B, location D) showed an absence of flow-induced thermal anisotropy. This orientation dependence obviated the requirement for precise sensor alignment to tube direction because of the ESA sensor density and cardinal symmetry.
A principal components analysis (PCA) model provided a facile method both for assessing catheter position with respect to the ESA ordinate system and for confirming the presence or absence of flow (Fig. 2C ). The PCA model, constructed from a time series ESA measurement, used DT i,k values to calculate the principal components (PC). DT i,k,t = D i,k,t − U t , where D i,k,t is the temperature for each sensor in the downstream sensor set at a particular time point (t) and U t is the temperature at the same time point from a single upstream sensor. The first two components (PC1 and PC2) described about 92% of the overall variability of the data (PC1, 70.5%; PC2, 22.1%) with the remainder (8% across PC3:PC50) associated with noise. PCA biplots (Fig. 2C) show projections of each DT i,k,t for two selected upstream sensors at each measurement in an ESA time series in two dimensions using the first two PCs. Data clustering (95% confidence ellipses) corresponding to three experimental conditions [absence of flow without thermal actuation (flow off/heat off), absence of flow with thermal actuation (flow off/heat on), and flow with thermal actuation with separate clusters for different flow regimes (0.02 and 0.2 ml/min)] shows that these clusters are independent of the selected U sensor (Fig. 2C and figs. S4 and S5) . A comparison of the data clusters and PC shows that PC1 primarily relates to the degree of thermal actuation, whereas PC2 relates to the presence or absence of flow. Mapping the variables to the PCA biplot indicates sensor correlation to flow. An overlay of four variable factors corresponding to D sensors known to be proximal (red) and distal (blue) to fluid flow shows the positive and negative correlations to flow for the proximal and distal sensors, respectively, for both orthogonal and inline U sensors (Fig. 2C) . PCA offers a strategy to mitigate effects of ESA misalignment by determining the U sensor that yields the maximum separation between no-flow and flow data clusters along the PC2 axis. The inline U sensor strongly separates these cluster groups as compared to the orthogonal U sensor (Fig. 2C) . For scenarios without a priori orientation, PCA offers a straightforward means for evaluating correlations between U and flow state and, therefore, orientation of the catheter relative to the ESA.
The density of the ESA enabled spatial mapping of the temperature anisotropy that resulted from flow. These maps resulted from the processing of raw measurements from the ESA (Fig. 2D) . First, by converting the raw ESA measurements (I meas ) to resistance and then temperatures by linear calibration [curve a priori established for each sensor of the ESA (see the "Spatial interpolation for heat maps" section in Supplementary Materials and Methods and fig. S6 )], the temperature values can be mapped to the physical spatial coordinates of each sensor on a simulated square "pixel" array larger than the ESA (grid: 17 mm by 17 mm, 10 pixels mm the measured T normalized values for each frame via meshed bicubic interpolation (boundary conditions T normalized = 0 from IR thermograph). Subtracting the actuator temperature and resulting isotropic heat transfer temperatures (T actuator ) from T normalized for every frame enhanced visualization of flow-induced anisotropic thermal transport. The high density of the ESA enabled good fidelity in visualizing the thermal anisotropy over the embedded catheter (Fig. 2D) . Although experiments with patients do not typically allow for direct measurements of the flow and no-flow cases, theoretically derived or a priori measured "calibration" T actuator facilitated the analysis (see the "Spatial interpolation for heat maps" section in Supplementary Materials and Methods).
Quantitative analysis of flow
Full mapping results obtained with the high-density ESA suggested means for simplifying the sensor to allow rapid measurements in a low-cost platform that consisted only of an actuator and a pair of sensors located 1.5-mm upstream (T upstream ) and downstream (T downstream ) of the actuator, respectively, which we refer to as an epidermal linear array (ELA; Fig. 3A ). In this system, the actuator simultaneously served as a temperature sensor, and the measured temperature of the actuator, T actuator , yielded a useful normalizing factor that facilitates data analysis independent of actuation power. Use of this system with a benchtop model allowed for the controlled exploration of the effects of flow, thermal, and geometric parameters ( fig. S7 ). Operating the actuator at a controlled, low-power (1.35 mW/mm 2 ) setting created heat that diffused through the silicone skin phantom at a rate governed by the thermal diffusivity of this material, a skin , with a characteristic penetration depth that can be expressed in the form of a dimensionless scaling law ( fig. S8) . Here, the phantom was treated as a semi-infinite solid (29) that approaches a quasi-steadystate equilibrium over relatively long (~400 s) times with a corresponding penetration depth of~6 mm, although the thermal anisotropy was measurable well before this time, as the time taken to achieve 63.7% (t) of the steady-state value is~40 s ( fig. S9 ). The transient sensor and actuator responses after actuation [DT sensors = T sensor (t) − T sensor (t actuation ); DT actuator = T actuator (t) − T actuator (t actuation )] for different flows (Q CSF ) appear in Fig. 3B . In the absence of flow (Q CSF = 0), thermal transport from the actuator occurred equally in the ±x,±y, and −z directions, resulting in equal values for DT upstream and DT downstream (Fig. 3B, unshaded) . The presence of flow led to a nonmonotonic effect on DT upstream and DT downstream . At low flow rates (0 ml/min < Q CSF < 0.05 ml/min), the fluid transported heat from the actuator preferentially to the downstream sensor and away from the upstream sensor, resulting in a measured increase in DT downstream , and decrease in DT upstream (Fig. 3B , blue shading). The resulting thermal anisotropy,~1 K, was two orders of magnitude above the temperature resolution of our sensors (0.02 K), as shown in extensive prior work (27) . At higher flow rates (0.05 ml/min <Q CSF <1 ml/min), the convective effects of the fluid dominated, leading to a net cooling effect on both sensors but at different rates, with DT upstream equilibrating at a lower value than DT downstream (Fig. 3B , orange and gray shading). The actuator was convectively cooled by the fluid at a rate governed by the magnitude of the flow, resulting in reductions of DT actuator in the presence of flow (Fig. 3B , blue curve). These effects appear in the normalized quantities T upstream /T actuator and T downstream /T actuator (Fig. 3C ). The nonmonotonic effects of flow for different skin thicknesses (h skin ) increased and decreased when considering the difference between the sensors (DT sensors /T actuator ) and their average ( T sensors /T actuator ), respectively ( T sensors /T actuator were measures of thermal anisotropy and flow magnitude, respectively. Together, these quantities allowed for determination of flow rate and were used to distinguish degenerate points on either side of the peak values (Fig. 3D) .
The thickness of the skin (h skin ) represents an important geometric parameter. Increasing h skin decreases the effects of flow on the sensor responses, simply because of the finite depth of penetration of the thermal field (Fig. 3 , D and E). Although transient techniques can be used to determine h skin from thermal measurements, in practice, h skin can be measured directly using CT and Doppler ultrasound. Typical ventricular catheters are implanted subcutaneously, as validated by radiographic and ultrasound imaging, at depths of 1 to 2 mm, within the range of detectability. Recent work (30) established a set of design considerations and algorithms for extracting depth-dependent thermal properties of soft tissue to depths of up to~6 mm. To account for patients with varying habitus, or extreme skin thickness, we tested in vitro trials on our phantom skin assembly, which showed the ability of the ELA to make measurements at depths of up to 6 mm ( Fig. 3F  and fig. S10 ).
The power/area of the actuator (P actuator ) represents an important design consideration. Increasing P actuator improves the signal-to-noise ratio (SNR) of the measurements, but biological considerations set an upper limit for noninvasive use. The effects of P actuator on SNR appear in Fig. 3G , where the signal is an averaged measurement over 60 s (measured at 5 Hz) of DT sensors /T actuator for a flow rate of 0.13 ml/min. The noise is the SD (s 60s ) computed to three digits. At sufficiently high values of P actuator (P actuator > 1 mW/mm 2 ), the advantages of increased actuation power diminished, and the noise stabilized at 2% of the measured signal. This power-invariant noise arises primarily from sampling noise inherent to the data acquisition system (DAQ) and from the time dynamic effects of convection. The effect of increased P actuator on T sensors and on T actuator appears in fig. S11 , demonstrating (i) a linear relationship between P actuator and T actuator and (ii) the diminishing effects of increased P actuator on the measured (T downstream − T upstream ).
The thermal conductivity (k skin ) and diffusivity (a skin ) of the skin also represent unknowns, with human skin exhibiting a range of 0.3 W m (31) . Analytical curve fitting of the transient actuator temperature response, DT actuator , to well-studied functional forms (32) yielded these two quantities for two phantom skins ( Fig. 3H ) with thermal properties that bound this range. The measured values of DT sensors /T actuator were nearly identical for these two cases, whereas the increased rates of thermal transport associated with Sylgard 170 increased the cooling effect of the fluid, thereby reducing the values of T sensors /T actuator (figs. S12 and S13). Ventricular catheters are constructed from standard medical-grade silicones, and their thermal properties were assumed to be known a priori (k catheter = 0.22 W m
) (33). Last, catheter geometry and the thermal properties (k CSF and a CSF ) of the CSF strongly influence the ultimate measurement, but they can also be assumed to be known a priori. A complete list of all thermal and geometric properties relevant to precise flow measurement, as well as their mode of acquisition, appears in table S1. Additional experiments quantified the convective heat transfer coefficient (H conv = 20 W m −2 K −1 ; fig.  S14 ), the tolerance in positioning to achieve <20% error (20°rotational tolerance, 0.5-mm translational tolerance; fig. S15 ), the effect of sensor distance from the actuator ( fig. S16) , and the high-and low-frequency noise introduced by the DAQ as a function of sampling window, motion, convection, anisotropic conductive film (ACF) cable, and nearsurface blood flow (figs. S17 to S21).
Wireless data acquisition via Bluetooth
Wireless data acquisition represents a key advance over previous demonstrations of epidermal temperature and flow sensors. Optical images of the wireless system demonstrate its flexibility and size (Fig. 4, A to C) . The fabrication approach integrated soft, stretchable, low-modulus (~1 MPa) sensing components with flexible printed circuit boards (flex-PCBs) that offered the robustness required to support critical commercial wireless electronic components, such as batteries, Bluetooth chips, and power regulators. With a soft, easily removable skin-safe adhesive, this design afforded advantages of epidermal electronics (low thermal mass and conformal contact) and the scalability of recent advances in flex-PCB manufacturing, yielding system-level flexibility and localized softness and stretch at the sensor. The entire system mounts on skin (Fig. 4C ) via a medical-grade acrylate-based sheet adhesive, with an adhesion energy (880 N/m) higher than the work of adhesion required to induce delamination at 15% strain (~5 N/m), the yield strain of skin, while allowing for nonirritating contact and easy removal. We constructed a customized temperature sensing and actuation circuit to perform wireless flow measurement (Fig. 4D) . Subtle changes in resistance (<1 ohm) that resulted from changes in temperature appeared as changes in voltage (V g ) across the arms of a Wheatstone bridge. The total increase in temperature (~3 K) during actuation resulted in V g < 10 mV, which is comparable to the resolution of an ADC with a 3.3-V range and 10-bit resolution (3.3 V/2 10 = 3.2-mV resolution) and is lower than the resolution limit of an 8-bit ADC (3.3 V/2 8 = 12 mV). An operational amplifier amplified this signal across the 3.3-V range to achieve the required sensing resolution. The resistances of the nonsensing arms of the bridge can be tuned to bring the measured changes within the range of the ADC, and a custom circuit simulation allows for facile fine tuning of the circuit before assembly.
A Bluetooth communication protocol is attractive because of its long range and compatibility with standard smartphones and tablet computers. A commercially available Bluetooth transmitter digitized and transmitted this signal with 200-Hz sampling frequency to a custom smartphone application. A miniaturized, rechargeable, Li-polymer battery supplied power and was regulated by a low-dropout regulator, resulting in a stable, 3.3-V output. Thermal actuation resulted from voltage supply to the actuator, creating heating power that was facilely tuned via Wheatstone bridge calibration, and from voltage modulation through a general-purpose input/output (GPIO) pin. An example of this appears in Fig. 4E , with 3.6 mW of actuating power resulting in a localized temperature rise of 8 K on a silicone skin phantom. In vitro experiments demonstrated the effects of flow on measured temperatures (Fig. 4F) , where the presence of flow (Q = 0.13 ml/min) through an underlying catheter resulted in a change in an adjacent sensor. Conversion of the raw, measured ADC values to temperature used a simple linear calibration (Fig. 4G) for two sensors on the same device, upstream and downstream of the catheter, acquired simultaneously with an 8-bit ADC. The utility of the system in performing wireless flow measurements is shown in Fig. 4H , where T downstream − T upstream is shown for two flows as a function of time.
Near-term goals in clinical monitoring informed key device features. Fully assembled, the wireless ELA was 1.8 cm by 4.1 cm in size, with a thickness that varied by location (4 mm at the battery,~100 mm everywhere else) and weighed 680 mg, with nearly half of this value from the battery (330 mg). During operation, the system consumed 6 mA of current. The rechargeable Li-polymer battery supplies 12 mAh at 4.2 V, resulting in a total working time of~2 hours. Typical monitoring requires 5 min, resulting in battery life of~6 days. The capacity can be readily increased via the use of a larger battery. The Bluetooth chip has 8 ADC pins, in addition to 20 GPIO pins, of which we use 2 and 1, respectively, suggesting straightforward pathways to expand the platform to realize fully wireless large-array sensors for complete spatial mapping using digital multiplexing schemes that use commercially available solid-state multiplexer/demultiplexer units (34) . The functionality of the wired data transmission, recording, and power transmission electronics was entirely transferred to the miniaturized wireless design ( fig. S22 ). Images and movies of the wireless system functioning via pairing with a smartphone application are shown in fig. S23 and movies S1 and S2, respectively.
Human studies for the evaluation of ventricular shunt function
Experiments on five shunt recipients with different pathologies demonstrated the clinical utility of the ELA measurement platforms. The device designs addressed three needs: (i) ease of handling for the surgeon to ensure facile placement and removal; (ii) comfort for the patient during application, operation, and removal; and (iii) robust mechanical and thermal coupling to the skin. The ELA had an ultrathin elastomer substrate (100 mm) supported by an elastomeric frame (2 mm; Fig. 5A ). The devices adhered robustly and noninvasively to the skin, maintaining conformal contact with the skin even under extreme deformations. Successive measurements required placement on the skin over the distal catheter ("on shunt") and at a location adjacent to the distal catheter ("off shunt"; Fig. 5B ). The off-shunt measurement had two key uses: (i) It served as a control for comparison to the on-shunt measurement, and (ii) it allows for the measurement of skin thermal properties without the influence of flow. Locating the catheter and positioning the ELA can typically be accomplished via touch in superficial regions, with further validation, as necessary, by hand-held Doppler ultrasound imaging (Fig. 5B, inset) . Linear markings on the device allowed for easy alignment of the central axis of the actuator and sensors with the underlying shunt. Although the shunt was not visible under the skin, its ends were easily aligned to the markings on the device via touch. Low-power actuation (1.3 mW/mm 2 ) ensured maximum temperature increases of <5°C, which were confirmed by IR imaging (Fig. 5C) . These values are below the threshold for sensation, in accordance with institutional review board (IRB)-approved protocols. Results showed a characteristic tear-drop distribution of temperature, consistent with the presence of flow.
The presence or absence of flow corresponding to shunt functioning or failure can be immediately determined simply by observing the presence or absence of thermal anisotropy. Measured values of DT sensors /T actuator (Fig. 5D ) for on-shunt and off-shunt locations for all five patients revealed anisotropy for all working shunts. Details of each patient's etiologies and results are shown in table S2, and raw, measured values of DT sensors /T actuator and T sensors / T actuator for each patient are shown in table S3. Averaged values of DT sensors /T actuator at on-shunt and off-shunt locations, for cases with surgically or clinically confirmed flow, revealed differences (P = 0.012, n = 5) between measurements made in the presence and absence of flow, respectively (Fig. 5E, table S4 , and raw readout in fig. S24 ). Images of the wired DAQ used for clinical studies appear in fig. S25 ; in vivo measurements of skin thermal properties appear in fig. S26 ; and simple validation studies on an external ventricular drain (EVD) appear in fig. S27 .
Studies by x-ray, MRI, and CT imaging validated the ELAderived measurements. Figure 6A corresponds to a patient (female, 36 years old) with a shunt malfunction suspected to be due to a kink in the distal catheter, which was confirmed by the x-ray and RSPS images. Surgical intervention relieved the kink, causing a visible increase in flow (Fig. 6B) . The continuous presence of flow was further confirmed via postoperative x-ray and RSPSs, revealing a straightened distal catheter and a clear trace beyond the valve (Fig. 6C) . Placement of the ELA at on-shunt and off-shunt locations, respectively, revealed no flow before the revision, consistent with x-ray and RSPS imaging. After operation, the off-shunt measurement showed no appreciable changes, whereas the on-shunt measurement showed the presence of flow (Fig. 6D) .
The quantitative extraction of flow rates from such data can be accomplished via fitting to FEA models that use measurements of k skin and a skin , DT sensors /T actuator , and T sensors /T actuator and a priori knowledge of the inner and outer diameters of the catheter and its thermal properties k catheter and a catheter (Fig. 7A) T sensors /T actuator fit to the computed curves yielded a nearly perfect match for a flow rate of 0.10 ml/min. In practice, experimental uncertainties in fitted values of h skin , k skin , and a skin demand the use of multiparameter fitting models that treat the above quantities as fitting parameters within a fixed, defined range. Practically, the precise determination of subtle, real-time changes in flow through a shunt, as an indicator of healthy, intermittent, or obstructed flow, respectively, takes precedence over an accurate measurement of true flow rate. We detail a simplified approach that defines an effective flow rate, as measured by our sensor. Here, k skin and a skin assume known values, and calculations yield a family of FEA curves for different skin thicknesses. Iterative fitting of experimental data points to this set of curves yields a flow rate, with the self-consistency requirement that the experimental values match curves for DT sensors /T actuator and T sensors /T actuator at the same values of Q and h skin (Fig. 7B) .
In vivo data (Fig. 7C ) demonstrated the utility of precise, effective flow rate measurements. Physician assessment and expected values of flow (28) for functioning and nonfunctioning shunts served as qualitative validation of these results. In patients 1 and 5, surgical observations confirmed our data. Assessments of patient 1 before corrective surgery indicated a shunt malfunction, consistent with ELA measurements (0.01 ± 0.01 ml/min). Measurements after a surgical revision revealed a flow rate of 0.06 ± 0.02 ml/min. Patients 2 and 3 were not suspected of shunt malfunction and exhibited flow rates of 0.36 ± 0.04 ml/min and 0.13 ± 0.02 ml/min, respectively, within established ranges for healthy CSF flow (28) . Patient 4, initially measured to have occluded flow (0.013 ± 0.002 ml/min), had experienced severe and prolonged constipation for the week before the measurement and clinically deteriorated because of a likely pseudo-obstruction. Long-term constipation can decrease the resorptive ability of the peritoneum because of increased intraabdominal pressure and a decreased pressure gradient from ventricle to peritoneum (35) . After administering a rigorous bowel regimen, the patient's mental status improved, and a subsequent measurement revealed healthy flow (0.16 ± 0.02 ml/min). Patient 5 was suspected to have shunt malfunction, and thermal measurements revealed highly occluded flow (0.027 ± 0.005 ml/min), which was later surgically confirmed. For these studies, the sensors were not used to make clinical determinations. In patients 4 (before bowel examination) and 5 (before surgery), the results of the measurements were blinded to the physician assessment (Fig. 7C) . In a practical sense, uncertainties in these measurements can largely be eliminated by establishing baseline healthy flow for each patient, either immediately after operation or during a routine checkup, during which the patient is not suspected of shunt malfunction. In this way, relative changes in flow can easily be assessed without requiring precise flow rates, and follow-up measurements can distinguish between healthy flow, intermittent flow, obstructed flow, and total shunt failure. A computationally simple, multiparameter fitting model for true flow rate determination forms the basis of future work.
Measurement error, noise, and uncertainty
The noise inherent to the DAQ, together with factors that attenuate the signal such as the effects of skin thickness, convection, and inplane heat dissipation, contributes to a total noise in benchtop flow measurements of DT sensors /T actuator of~2% of signal in uncovered measurements, with detailed description of these noise sources appearing in the Supplementary Materials (see the "DAQ noise" in Supplementary Materials and Methods). In vivo measurements introduce noise due to motion of the subject that results in bending and deformation of the ELA and of the interface between the ultrathin, soft device and ACF cable. These effects appear in fig. S19 , with optical images illustrating the ELA over deformed and undeformed skin as shown in fig. S19A . Time and frequency domain temperature data measured over 400 s on a stationary subject appear in fig. S19 (B to D), demonstrating primarily low-frequency natural temperature oscillations of 0.2 K, consistent with previous reports (27) . Although convection could pose another potential source of noise, this affects both sensors and the actuator equally, and as such, these changes will largely disappear in analysis approaches that rely on differentials between these two quantities. Deliberate deformation results in characteristic noise associated with vigorous motion, gentle motion, strain on the ELA, and complete delamination, as shown in fig. S19 (E to G). In practice, mechanical motions of the ACF cable and induced stresses/strains at the soft bond pads created by motions of the patient are the primary sources of noise, which we measure in vivo, on average, to be 9 to 10% of the measured DT sensors /T actuator signal for all patients (on on-shunt locations). Elimination of the ACF cable, through wireless embodiments, or enhancements of its interfaces to the bond pad with soldered connections may mitigate these effects. Altered intersensor distances due to the stretchability of the sensor represent another source of uncertainty. The peak sensitivity to flow changes occurs at L = 2.5 mm upstream and downstream from the edge of the actuator (fig. S16 ). Uniaxial strain of 15% (the yield strain of skin) at this distance corresponds to a positional uncertainty of ±0.375 mm, and although this results in an uncertainty in flow determination of~10%, it does not compromise the ability to unambiguously determine the presence or absence of flow. In addition, our use of a medical-grade adhesive silicone ensured that the sensor did not move laterally in relation to the catheter. A complete discussion of the technical challenges faced during the clinical trials and their solutions is shown in table S5.
Comparison to recent technologies A commercially available sensor (ShuntCheck) offers an alternative to imaging-based diagnostic tools (5, 7, 14, 36) . The system comprises a cooling pack that is held against the skin over the distal catheter, with conventional, bulk temperature sensors attached to the skin downstream, along the direction of the catheter. The pack cools flowing CSF, thereby decreasing the temperature of the downstream sensor. Although this system has high specificity (~100%) (7) and sensitivity (80%), it suffers from key limitations. First, the embodiment is bulky and offers a poorly coupled sensorskin interface that demands the use of a large pack (2.5 cm by 2.5 cm) and significant cooling. This requirement, together with a conventional, large-scale DAQ, decreases the usability of the system and prevents continuous, long-term measurements, precluding the ability to measure intermittent flow and to use patients' past data as a reference. Second, the measurements are semiquantitative, without an ability to account for key factors such as skin thickness, skin thermal properties, and device layout. Together, these factors lead to overall patient discomfort and prevent straightforward interpretation of data (7) . A comparison of existing diagnostic techniques is shown in table S6 .
DISCUSSION
The goal of the study was to validate our sensor's performance through a range of in vitro and in vivo testing. In vitro testing yielded the effects of key physical variables, such as varying flow rates, skin thicknesses, and actuating power, whereas in vivo tests provided insights into both device performance and practical aspects such as device handling and ease of use. The sensor was able to capture differences between cases with flow and no flow (P = 0.012) in vivo, as validated clinically by either imaging or surgical evaluation.
Detailed descriptions of patient trials
Consistent with early adoption of any novel technology, there was a learning curve associated with locating the tunneled distal shunt tubing, manipulating the device, identifying an ideal placement location, appropriately laminating the device to the patient, maintaining patient position, and preventing patient motion with resultant noise artifact generation. However, thoughtful modifications based on feedback after the first patient study resulted in rapid improvements.
Connecting the proximal and distal sites of shunt tubing generally involves tunneling the catheter subcutaneously. In the case of peritoneal catheters, this is accomplished by a surgeon operating proximally at the cranial aspect of the patient, passing a long, sharp trocar containing distal shunt tubing under the skin from the incision, maneuvering it over the clavicle, and then placing it with a recipient surgeon to be inserted into peritoneum. This tubing is connected to the valve assembly, which is then connected to the proximal catheter. Flow is confirmed through the system after all lines are flushed of air and CSF drainage commences. Tunneling of the catheter occurs above the clavicle to prevent inadvertent complications from piercing the thoracic viscera, including the lung, mediastinum, and heart. It is at this point that the catheter is uniformly superficial (<2 mm) in most shunted patients.
After location of optimal sensor placement site, handling the device was problematic during the initial patient trial. As a soft, flexible device lined with adhesive, it lined to surgeon hands, was difficult to align with the underlying shunt tubing, and delaminated with factors including patient movement, repetitive device uses, and repositioning. Alignment relied on positioning the central core of the sensor over the shunt tubing, which proved problematic with an adherent device. Further, inappropriate handling led to mechanical destruction of the underlying electronics, leading to aberrant readings. All of these problems were addressed after one substantive device improvement was performed, improving its efficacy throughout the duration of the subsequent patient trials. The redesign of the device considered many of factors, largely focusing on enclosure and adhesive capabilities. An elastomeric enclosure was laser-structured and added to the sensor as a handling frame. This achieved two marked performance improvements: First, by confining the adhesive to a limited area, a barrier was created between the sensor and the surgeon's gloves, minimizing challenges associated with handling. Second, by marking lines corresponding with the central axis of the sensor, the surgeon's device placement became straightforward after the localization of the tunneled distal catheter tubing. Clinical-grade adhesive silicone (Q adhesion = 160 N/m; MG 1010, Dow Corning) was also applied to the underside of the device, which permitted secure initial placement and weathered patient movement and multiple uses. This had no effect on the superficial skin, with no skin irritation noted nor expressed by trial subjects.
As positionality is a variable with known effect on shunt performance, it was controlled by examining all patients upright in their hospital bed. Maintaining this position was challenging in certain patients because of factors including boredom, discomfort, postsurgical or chronic pain, and cognitive disability. The presence of family members often helped with these challenges, offering conversation, empathy, or advice to allow for trials to run unencumbered. As an unintended side effect, in all successive trials, patient family members and caregivers expressed enthusiasm for the sensor's design and form factor.
Last, we noted motion noise during patient movement. These movements ranged from normal respirations to positional shifts due to the factors listed above, with detailed descriptions in Results. After examination of the device and its components, it was noted that the predominance of noise-related issues transpired because of fluctuations in the ACF cables used. This prompted the development of the wireless device iteration.
Certain unusual circumstances over the course of the patient trials warrant further discussion. After initial surgical shunt placement, patient 4 was noted to subjectively cognitively deteriorate by nursing staff. A sensor reading was obtained during this period, although the study team attributed these symptoms initially to recovery from anesthetic. No flow was ascertained during this measurement. When the patient became further obtunded and unarousable, it was revealed that the patient had not stooled in 1 week, with an abdominal x-ray performed displaying a substantive stool burden. A laxative regimen was administered overnight, and a follow-up sensor reading demonstrated normal catheter flow. This was congruent with the known phenomena of pseudomalfunction, wherein severe constipation, urinary tract infection, and inability to void have clinically produced the clinical symptoms of shunt malfunction. Further research is necessary to provide exact specifics as to the nature and mechanics of these malfunctions, but it was interesting to quantitatively capture this phenomenon in real time. Last, patient 5 was suspected to have shunt malfunction and had been recently admitted for a surgical revision. However, a preoperative sensor measurement revealed the presence of occluded flow that was confirmed hours later over the course of surgery.
Limitations of our study For robust, reliable clinical shunt monitoring, we recognize the need for careful validation to study a range of long-term factors, such as body habitus, collagen scar tissue formation, or calcification of the shunt, and how they interfere with our measurements. However, to a reasonable approximation, these changes will affect the upstream and downstream temperature sensor equally, and as such, these changes will largely disappear in analysis approaches that rely on differentials between these two quantities. In addition, although we were able to detect statistically significant (P < 0.05) differences in cases with (on shunt) and without (off shunt) flow, respectively, the low sample size represents an important caveat and suggests the need for a larger-scale study to further validate our findings. Last, we recognize the need for clinical validation of our wireless embodiment, which, along with the need for larger sample size, informs the design of a larger clinical trial based entirely on the wireless embodiment.
Implications for hydrocephalus treatment and research Overall, the skin-like, precision sensor systems introduced here have the potential to represent a paradigm shift in clinical diagnostics of shunt malfunction. Compared to radiographic imaging, invasive sampling, and ice pack cooling, these platforms are unique in their integration of precision, soft, thermal sensors with wireless transmission capability. By exploiting advanced concepts in the measurement of thermal anisotropy and skin-conformal epidermal electronics, these devices can provide further quantitative modes of use beyond opportunities afforded by the embodiment studies here. For example, comparison of measured, quantitative flow rates from the ELA can be used in conjunction with a manufacturer-supplied calibration chart to measure intracranial pressure. In addition, prior work (23) has established the suitability of related device in measurements of near-surface blood flow, which can be applied to study neural blood supply. Many poorly understood conditions stem from neurological hydrodynamic dysfunction, including normal pressure hydrocephalus and idiopathic intracranial hypertension. By understanding individual flow rates in these conditions, novel and improved treatment approaches can potentially be developed for their care.
MATERIALS AND METHODS
Study design
The goals of the study were to design and fabricate our novel, soft epidermal sensors and to validate their performance against clinician diagnosis, surgical observation, and imaging results. Patients were recruited from the population of the study site (Northwestern Memorial Hospital, Chicago, IL; IRB protocol STU0020542). Inclusion criteria specified patients with previously implanted ventricular shunts undergoing evaluation or routine follow-up and patients undergoing new ventricular shunt placement procedures. The study was not formally blinded, although sensor measurements were performed and analyzed without previous knowledge of imaging or surgical results. Patients were evaluated at a 45°angle during device placement. Sensor placement was determined on the basis of touch to locate the most superficial location of the shunt, either over the clavicle or on the neck. A single measurement consisted of placing the sensor on the skin and waiting for 60 s for the sensor to equilibrate with the skin. Low-power thermal actuation (1.6 mW/mm 2 ) was then supplied for 240 s and then halted for the next 120 s, while making continuous temperature measurements of both the sensors and the actuator. All data recording occurred at 5 Hz, and all data processing used an adjacent-averaging filter with a 10-point sampling window. Two successive measurements each were made on the skin directly overlying the shunt and at a skin location adjacent to the shunt. The shunt was easily located, and alignment marks on the device allowed for easy alignment. An elastomeric enclosure around the device facilitated handling of the device. Details of each patient and their etiologies appear in table S2, and individual patient-level data are shown in table S3.
Statistical analysis
Data are presented with average values and SD, unless noted in the figure caption. Paired t tests performed on SPSS (IBM Inc.) compared thermal measurements in the presence and absence of flow. PCAs of the ESA data were performed using the R statistical language. Linear regression analysis of measured sensor data was used to generate temperature calibration curves for all sensors and to determine thermal conductivity using MATLAB. Quantitative flow analysis was conducted on measured data via fitting analysis in MATLAB using numerical relationships calculated via Finite Element Modeling (ABAQUS).
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